We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ASPU
2876
DELISTED
ASPEN GROUP, INC.
ASPU
| $136K | ﹤0.01% |
+15,078
| New | +$124K |
|
|
TYME
2877
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
| $136K | ﹤0.01% |
102,631
+5,770
| +6% | +$7.87K |
|
|
WBK
2878
DELISTED
Westpac Banking Corporation
WBK
| $136K | ﹤0.01% |
+10,858
| New | +$119K |
|
2879
Fortress Biotech
FBIO
$88.7M
| $135K | ﹤0.01% |
+3,368
| New | +$125K |
|
2880
GSI Technology
GSIT
$258M
| $135K | ﹤0.01% |
18,813
+2,967
| +19% | +$21.5K |
|
2881
InfuSystem Holdings
INFU
$249M
| $135K | ﹤0.01% |
+11,732
| New | +$135K |
|
2882
Nature's Sunshine
NATR
$288M
| $135K | ﹤0.01% |
15,008
+1,205
| +9% | +$10.5K |
|
2883
Ponce Financial Group
PDLB
$485M
| $135K | ﹤0.01% |
18,563
-7,242
| -28% | -$47.5K |
|
2884
Quantum Corp
QMCO
$474M
| $135K | ﹤0.01% |
+1,749
| New | +$138K |
|
2885
Gold Fields
GFI
$36.5B
| $133K | ﹤0.01% |
+14,118
| New | +$107K |
|
2886
Smith Micro Software
SMSI
$16.2M
| $133K | ﹤0.01% |
+748
| New | +$135K |
|
2887
Veru
VERU
$37.4M
| $133K | ﹤0.01% |
+3,970
| New | +$137K |
|
|
ARAV
2888
DELISTED
Aravive, Inc. Common Stock
ARAV
| $133K | ﹤0.01% |
+11,460
| New | +$136K |
|
|
RRD
2889
DELISTED
RR Donnelley & Sons Co.
RRD
| $133K | ﹤0.01% |
111,678
-140,277
| -56% | -$171K |
|
|
PEI
2890
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $133K | ﹤0.01% |
6,521
-9,236
| -59% | -$167K |
|
2891
Evolution Petroleum
EPM
$131M
| $132K | ﹤0.01% |
47,121
+11,245
| +31% | +$30.2K |
|
|
MRLN
2892
DELISTED
Marlin Business Services Corp
MRLN
| $132K | ﹤0.01% |
15,599
+990
| +7% | +$7.68K |
|
2893
Capital Bancorp
CBNK
$615M
| $130K | ﹤0.01% |
12,171
-2,671
| -18% | -$28.9K |
|
|
EEX
2894
DELISTED
Emerald Holding
EEX
| $130K | ﹤0.01% |
42,077
-45
| -0.1% | -$107 |
|
|
STEX
2895
Streamex Corp
STEX
$83M
| $129K | ﹤0.01% |
1,797
+624
| +53% | +$54.3K |
|
2896
Lexicon Pharmaceuticals
LXRX
$1.1B
| $129K | ﹤0.01% |
64,886
+8,279
| +15% | +$16.2K |
|
|
RJET
2897
Republic Airways Holdings
RJET
$1B
| $129K | ﹤0.01% |
2,497
+812
| +48% | +$43K |
|
2898
Nomura Holdings
NMR
$29.1B
| $128K | ﹤0.01% |
28,905
+6,257
| +28% | +$26K |
|
|
ORGS
2899
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $128K | ﹤0.01% |
+2,100
| New | +$127K |
|
|
SBBP
2900
DELISTED
Strongbridge Biopharma plc.
SBBP
| $128K | ﹤0.01% |
33,786
-5,131
| -13% | -$15.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.